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Abstract
Objective: UK Indian adults have higher risks of coronary heart disease and type 2 diabetes than Indian and UK European
adults. With growing evidence that these diseases originate in early life, we compared cardiometabolic risk markers in
Indian, UK Indian and white European children.
Methods: Comparisons were based on the Mysore Parthenon Birth Cohort Study (MPBCS), India and the Child Heart Health
Study in England (CHASE), which studied 9–10 year-old children (538 Indian, 483 UK Indian, 1375 white European) using
similar methods. Analyses adjusted for study differences in age and sex.
Results: Compared with Mysore Indians, UK Indians had markedly higher BMI (% difference 21%, 95%CI 18 to 24%), skinfold
thickness (% difference 34%, 95%CI 26 to 42%), LDL-cholesterol (mean difference 0.48, 95%CI 0.38 to 0.57 mmol/L), systolic
BP (mean difference 10.3, 95% CI 8.9 to 11.8 mmHg) and fasting insulin (% difference 145%, 95%CI 124 to 168%). These
differences (similar in both sexes and little affected by adiposity adjustment) were larger than those between UK Indians
and white Europeans. Compared with white Europeans, UK Indians had higher skinfold thickness (% difference 6.0%, 95%CI
1.5 to 10.7%), fasting insulin (% difference 31%, 95%CI 22 to 40%), triglyceride (% difference 13%, 95%CI 8 to 18%) and LDL-
cholesterol (mean difference 0.12 mmol/L, 95%CI 0.04 to 0.19 mmol/L).
Conclusions: UK Indian children have an adverse cardiometabolic risk profile, especially compared to Indian children. These
differences, not simply reflecting greater adiposity, emphasize the need for prevention strategies starting in childhood or
earlier.
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Introduction
People of Indian origin migrating to the UK have experienced
rates of coronary heart disease (CHD) and type 2 diabetes (T2D)
which are markedly higher than those of the white European host
population [1,2] and those of their country of origin [3], though
risks of CHD and T2D in India are now rising rapidly [4].
Although comparisons of cardiometabolic risk factors between
Indian adult migrants and the white European host population
have shown that adiposity and insulin resistance are higher among
UK Indians [1,5], assessment of the full extent of migration-
related risk factor changes requires comparisons between Indians
living in India and in the UK or other Western diaspora locations
[6]. Such comparisons, few in number, have observed marked
differences in LDL-cholesterol and blood pressure as well as
adiposity and insulin resistance [6,7]. In the most recent UK-based
study, increased adiposity was identified as a key factor underlying
migration-related changes in cardiometabolic risk [6].
CHD and T2D risks are influenced by factors operating in
childhood, infant and fetal life [8,9]. Earlier reports have suggested
that differences in adiposity and insulin resistance between UK
South Asians and UK white Europeans are apparent both in
childhood [10–12] and adolescence [13,14]. However, differences
in cardiometabolic risk factors between Indian children living in
India and the UK, and the contribution of adiposity, have been
little studied [6]. We have therefore compared cardiometabolic
risk factors among 9–10 year-old Indian children examined in
comparable recent surveys in India and the UK; data on UK
white European children have also been included for reference.
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Methods
Analyses were based on two studies, the Mysore Parthenon
Birth Cohort Study (MPBCS) and the Child Heart and Health
Study in England (CHASE). MPBCS is based on 663 normal
births delivered at the CSI Holdsworth Memorial Hospital in
Mysore, India during 1997–1998. 630 participants were eligible
for follow up at approximately 9.5 years during 2007–2008.
Ethical approval was obtained by the CSI Holdsworth Memorial
Hospital ethical committee. Mysore is a burgeoning medium-scale
city in southern India and a base to several traditional and home
industries, and recently to a growing IT sector. The city has a
population of one million which is mainly of middle socio-
economic class. CHASE is a cross-sectional study of approximately
5000 9–10 year-old children who attended 200 Primary Schools in
London, Birmingham and Leicester carried out between 2004 and
2007. The study population is multi-ethnic and included children
of Indian and white European ethnic origins. Ethical approval was
obtained from the Multicentre Research Ethics Committee. Full
details of both studies are published elsewhere [10,12,15,16]. In
both studies, informed written consent was obtained from all
parents or guardians and assent from participating children.
Trained observers made standardized measurements of height,
weight, waist and mid-upper arm circumference, triceps and
subscapular skinfold thickness measurements using similar tech-
niques. Arm-leg bioimpedance was recorded with a Bodystat
Quadscan (MPBCS) or Bodystat 1500 (CHASE) (Bodystat Ltd,
Isle of Man, UK) using the same validated equation in both studies
to derive fat-free mass [17] and pubertal status assessed in girls
using the Tanner breast development scoring system. Two seated
measurements of blood pressure were made with a Dinamap 8100
(Critikon Inc, Tampa, Florida) in MPBCS or an Omron HEM-
907 (Omron Healthcare, Inc., Kyoto, Japan) in CHASE.
Appropriate cuff sizes were available in each study and room
temperature was recorded. Dinamap 8100 blood pressures were
calibrated to the standard mercury sphygmomanometer using
pooled estimates derived from published calibration studies [18–
20]; such adjustments were not needed for the Omron HEM-907
[21].
In both studies, blood samples were collected after overnight
fasting. In MPBCS, EDTA plasma samples were frozen within 2–
3 hours at 280uC and transferred to King Edward Memorial
Hospital, Pune for analysis on study completion. Glucose,
triglycerides, total and HDL cholesterol concentrations were
analysed with standard enzymatic methods (Alcyon 3000 autoan-
alyzer; Abbott Laboratories) and plasma insulin with a time-
resolved, fluoroimmunoassay (DELFIA) method (PerkinElmer Life
and Analytical Sciences, Wallac Qy, Turku, Finland). In CHASE,
plasma and serum samples were transferred to the Department of
Clinical Biochemistry, Newcastle Hospitals NHS Trust within
48 h of collection. Plasma glucose was measured using the
hexokinase method. Serum triglyceride, total and HDL-cholester-
ol were measured using an Olympus autoanalyser. Serum for
insulin measurement was separated and frozen on dry ice after
collection and analysed using an ELISA method which does not
cross-react with proinsulin [22] in the Department of Medicine,
University of Newcastle, UK. In both studies, LDL cholesterol was
estimated using the Friedewald formula [23] and the homeostasis
model assessment (HOMA) equations were used to provide
estimates of insulin resistance and beta cell function [24]. To
examine the influence of laboratory on blood marker patterns,
EDTA samples from 26 CHASE participants stored at 270uC
since collection were sent to the Pune laboratory for analysis
following MPBCS protocols during 2010.
In CHASE, child ethnicity was defined using parental
information on the self-reported ethnicity of both parents, or
parental information on the ethnicity of the child. The ‘UK
Indian’ group includes children whose parents both originated in
India and ‘UK white European’ includes children whose ethnicity
was defined as ‘white British,’ ‘white Irish,’ or ‘white European’
Statistical methods
Statistical analyses were carried out using STATA/SE software
(Stata/SE 10 for Windows, StataCorp LP, College Station, TX,
USA). Variables were checked for normality and log transformed
where necessary. Outcome variables which required log transfor-
mation included weight, BMI, waist and arm circumference,
triceps and subscapular skinfolds, sum of skinfolds, triglyceride,
fasting glucose and insulin, HOMA insulin resistance and beta cell
function. The average age of the two study populations was slightly
different and it was necessary to adjust for age as a confounder.
The similarity of associations with age in the different study
populations was formally examined; no marked differences in age
slopes were observed and age adjustments were made using a
single slope. Linear regression was used to create adjusted means
and population differences, adjusting for age and sex (except in
analyses where adjusted means are presented stratified by sex).
Means were standardized to the average age. Adjusted geometric
means and percentage differences were given for log transformed
variables.
In order to examine whether the associations between BMI, fat
mass percentage and sum of skinfolds differed between population
groups, median spline plots were created using the MSPLINE
command in Stata, which fits a smooth polynomial function to
show the inter-relationships between BMI and fat mass percentage
or sum of skinfolds (adjusted for age) in the different populations.
Population differences in BMI at a given level of fat mass
percentage (or sum of skinfolds) in different population groups
were estimated using regression models which included an
interaction term between population group and fat mass
percentage or sum of skinfolds. Absolute differences in BMI were
approximated from differences in log BMI by multiplying the
proportional differences by the expected median BMI. These were
estimated empirically by calculating the median BMI within 5
percentiles either side of the median for fat mass percentage or
sum of skinfolds for all population groups combined.
Population differences in cardiometabolic risk markers were
additionally adjusted for adiposity and height to examine whether
these explained the differences observed, having first established
that there were no consistent differences in the associations
between adiposity, height and cardiometabolic risk markers
between the three groups. Sensitivity analyses were conducted,
in which girls with a Tanner breast development score greater
than one were excluded from the analysis to remove girls who
showed evidence of pubertal development. Paired mean or
percentage differences and t-tests were used to quantify laboratory
differences based on analyses of blood samples from the same
individuals.
Results
In MPBCS, 538 children (256 boys and 282 girls, mean age 9.4
years) participated and had full measurements (85% of all
surviving birth cohort participants). In CHASE, 483 UK Indians
and 1375 white Europeans (948 boys and 910 girls, mean age 10.0
years) participated (75.1% of Indians and 69.4% of white
Europeans invited). Among the UK Indian children, most (83%)
were born in the UK; 12% were born in India and 4% in other
Cardiometabolic Risk Markers in Indian Children
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locations (for 1% birth place was unknown); their parental
occupations were 31.3% managerial/professional, 33.8% inter-
mediate and 26.5% in routine/manual; the remaining 8.4% were
unemployed or had unknown occupations) [25]. Mean levels of
adiposity and cardiometabolic risk factors are shown for boys and
girls in each population group (Table 1) and overall population
mean differences in these outcome measures (which were similar
in boys and girls) in Table 2. Differences expressed as z-scores are
presented in Supporting Information Table S1.
Differences between Indian and UK Indian children
Compared with Mysore Indian children, UK Indians were
taller (mainly reflecting greater leg length); heavier and more
adipose (higher mean BMI, waist and arm circumferences,
subscapular and triceps skinfolds and fat mass percentage). They
had higher fasting insulin concentrations, insulin resistance, beta
cell function, HDL-and LDL-cholesterol concentrations, and
systolic and diastolic blood pressure. Their mean triglyceride
levels were however similar to those of Mysore Indians, while
glucose levels were lower. The largest percentage differences
(,145%) and z-score differences (1.3–1.5) were observed for
fasting insulin, insulin resistance and beta-cell function. White
Europeans generally showed similar, though slightly smaller,
differences from Mysore Indians, except that their trunk length
and leg lengths were greater and triglyceride levels were lower.
Differences between UK Indian and UK white European
children
Differences between UK Indians and white European children
were less marked than those between UK Indians and Mysore
Indians (Table 2). UK Indians had a similar mean height but were
lighter and had lower mean BMI, waist and arm circumferences
than white Europeans. However, UK Indians had higher mean fat
mass % and skinfold thickness (particularly subscapular skinfold);
fasting insulin, insulin resistance and beta-cell function were
markedly higher, while triglyceride, diastolic (though not systolic)
blood pressure, total and LDL-cholesterol were all slightly higher.
Fasting glucose and HDL-cholesterol were similar. Again the
largest differences, both percentage (,30%) and z-score (,0.4)
were observed for fasting insulin, insulin resistance and beta cell
function. The differences were similar in boys and girls and were
little affected by adjustment for pubertal status in girls (data not
presented). Differences between UK Indians and other population
groups were similar in participants who were UK born and those
who were not (data not presented).
Population differences in the relationship between
adiposity and BMI
The inter-relations of BMI, fat mass % and sum of subscapular
and triceps skinfolds in the three study populations are shown in
Figure 1, with estimated absolute differences in BMI at the median
fat mass percentage and sum of skinfolds shown in Table 3. For
any given fat mass percentage (or sum of skinfolds), mean BMI was
highest among white Europeans, intermediate among UK Indians
and lowest among Mysore Indians, except at the lower end of the
distribution where Mysore Indians had similar or higher BMI
levels than UK Indians. Conversely, at any given BMI, fat mass
percentage (or sum of skinfolds) was lowest among white
Europeans, intermediate among UK Indians and highest among
Indians. At the median fat mass percentage, UK white European
children had a mean BMI,3.0 kg/m2 higher than Mysore Indian
children, while UK Indians had a BMI level ,1.8 kg/m2 higher
than Mysore Indian children; these differences were larger in girls
than boys. The corresponding BMI differences for sum of skinfolds
were slightly smaller; again these differences were slightly larger in
girls than boys (Table 3). In similar comparisons of UK Indians
and white Europeans, UK Indians had a BMI level 1.0 kg/m2
lower than white Europeans both at the median fat mass
percentage and the median sum of skinfolds; for fat mass
percentage this difference was very slightly higher in boys than
girls.
Effect on population differences of adjusting for
adiposity and height
Adiposity markers were strongly correlated with insulin, insulin
resistance, triglyceride, LDL-cholesterol and blood pressure in all
population groups (data not presented). The effects of adiposity
adjustment (with fat mass percentage and sum of skinfolds) on the
population differences in blood markers and blood pressure are
shown in Table 4; percentage changes in the population
differences in cardiometabolic risk markers after adjustment for
adiposity are shown in Supporting Information Table S3. The
differences between UK Indian and Mysore Indian children in
mean levels of insulin, insulin resistance and beta cell function
were reduced by at most one third, while differences in total and
LDL-cholesterol and blood pressure were little affected; differences
in glucose and HDL-cholesterol became more marked. All these
differences remained highly statistically significant. Adjustment for
adiposity had similar effects on UK Indian-white European
differences, reducing those in insulin, insulin resistance and beta-
cell function by up to one quarter, with smaller effects on
differences in diastolic blood pressure, total and LDL-cholesterol
and triglyceride. Again, all differences remained highly statistically
significant.
Height was strongly correlated with insulin, insulin resistance
and blood pressure in all population groups. Adjustment for height
in addition to adiposity (Supporting Information Table S2) led to
slight further reduction in the differences between UK Indians and
Mysore Indians in blood pressure, insulin, insulin resistance and
beta-cell function, with no effects on total, LDL and HDL-
cholesterol and an increase in the difference in fasting glucose; the
differences however remained substantial and statistically signifi-
cant. UK Indian-white Europeans differences were unchanged by
additional adjustment for height.
Laboratory comparison
Paired sample comparisons between the CHASE and MPBCS
laboratories are summarized in Supporting Information Table S4.
Mean insulin and triglyceride levels were slightly higher in the
CHASE laboratory; the triglyceride difference was statistically
significant. Total, LDL and HDL cholesterol levels were slightly
higher in the MPBCS laboratory; the total cholesterol difference
was statistically significant. The CHASE-MPBCS laboratory
differences in insulin were substantially smaller than the observed
study population differences and even the upper 95% confidence
interval could not explain the observed population differences;
laboratory differences in total, LDL and HDL cholesterol were
small and opposite in direction to the observed population
differences.
Discussion
UK Indian children had substantially higher levels of adiposity,
insulin resistance, LDL- and HDL-cholesterol and blood pressure
than Mysore Indian children. They also had higher levels of
adiposity, insulin resistance, LDL-cholesterol and diastolic blood
pressure than UK white European children, though differences
Cardiometabolic Risk Markers in Indian Children
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were less marked. At any given fat mass percentage, BMI was
highest in white Europeans, intermediate in UK Indians and
lowest in Mysore Indians. Conversely, at an equivalent BMI, body
fat levels (based on fat mass percentage and skinfolds) were highest
in Mysore Indians, intermediate in UK Indians and lowest among
white Europeans. The differences in insulin concentrations and
estimated insulin resistance and beta cell function between these
population groups were modestly reduced by adjustment for
adiposity markers (by approximately 30%); adjustment for
adiposity had little impact on differences in other risk markers.
We are not aware of previous comparisons between Indian
children in India and the UK, though previous adult studies have
compared UK Punjabi migrants with siblings in the Punjab [7]
and UK Gujaratis with Gujaratis in their villages of origin [6].
Those studies also showed higher levels of adiposity, insulin
resistance, total-cholesterol and blood pressure in UK Indians.
However, the differences in the present study appeared larger –
fasting insulin concentration in UK Indian children was more than
twice as high, compared with a one-third increase in the largest
adult study [6], while differences in total and LDL-cholesterol
(0.8 mmol/L, 0.5 mmol/L respectively) were also larger than
previously reported in adults (0.5 mmol/L, 0.3 mmol/L respec-
tively). Differences in systolic and diastolic blood pressure in the
present study (10.3 mmHg, 7.7 mmHg respectively) were similar
to those reported in adults (13.0 mmHg, 8.0 mmHg respectively)
[6]. The higher HDL-cholesterol and the lower plasma glucose
concentrations in UK Indians were also consistent with earlier
findings in adults [6]. The differences between UK Indians and
white Europeans (particularly in fat mass %, skinfold thickness and
insulin resistance) are consistent with previous reports on UK
South Asian children [10–12] and adults [5].
Strengths of the present investigation include the large size of
the study populations (sufficient for the detection of modest risk
factor differences) and the similarity of measurements and
measurement techniques in CHASE and MPBCS, with scope
for adjustment for method differences where present (e.g. for blood
pressure). The equation used for deriving fat mass % from
bioimpedance, though derived in white European children, has
been validated in Indian children; it provided close agreement
with estimates of fat mass % derived from doubly labeled water in
girls, though it may have underestimated fat mass % in boys [26].
Both study laboratories were externally standardized; between-
laboratory comparisons suggested that only a small component of
the observed between-population differences in insulin and none
of the observed differences in total, LDL and HDL cholesterol
between Mysore and UK Indians could be explained by
laboratory measurement differences. Adjustment for small differ-
ences in mean age between the study populations was undertaken.
Figure 1. Interrelationships between measures of adiposity adjusted for age in white Europeans (long dashes), UK Indians (solid
line) and Indians (short dashes) using median splines. Data are adjusted for age and presented between the 5th and 95th percentiles for the
variable on the horizontal axis by removing the bottom 5th and top 5th centiles from each population group separately. The y-axis is on the log scale.
doi:10.1371/journal.pone.0036236.g001
Table 3. Estimated population differences in BMI at median adiposity (fat mass % or sum of skinfolds) levels in whole study
population: for all children and by sex.
Explanatory variable Estimated absolute difference in BMI (95% CI)
UK Indian - UK white European - UK Indian -
Indian Indian UK white European
Fat mass % All 1.79 (1.51, 2.09) 2.96 (2.70, 3.24) 21.00 (21.17, 20.82)
Boys 1.16 (0.77, 1.56) 2.38 (1.99, 2.77) 21.07 (21.28, 20.85)
Girls 2.03 (1.59, 2.48) 3.14 (2.75, 3.54) 20.94 (21.23, 20.64)
Sum of skinfolds (mm) All 1.50 (1.30, 1.71) 2.69 (2.50, 2.88) 21.02 (21.16, 20.88)
Boys 1.30 (1.02, 1.58) 2.46 (2.20, 2.73) 21.02 (21.19, 20.84)
Girls 1.65 (1.33, 1.97) 2.89 (2.61, 3.17) 21.06 (21.28, 20.83)
Estimated population differences were evaluated at the median level of adiposity (fat mass % or sum of skinfolds) and were adjusted for age and sex (except by sex),
population group and an interaction term between population group and the adiposity marker. Population differences presented separately for boys and girls were
from a stratified analysis by sex.
doi:10.1371/journal.pone.0036236.t003
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The observed differences between Indian and UK children are
strongly coherent; adiposity differences expressed as SD scores are
similar for a wide range of independently assessed markers,
suggesting that the comparisons are valid. Although the two
studies had different designs (CHASE was cross-sectional and
MPBCS a birth cohort, both are effectively treated as cross-
sectional studies in this investigation. The slight difference in the
time periods in which these cross-sectional studies were carried out
(CHASE between 2004 and 2007, MPBCS between 2007 and
2008, a median difference of 1 year 8 months) is unlikely to have
an appreciable effect on the results. In supplementary analyses, we
have modeled time trends in adiposity and cardiometabolic risk
markers within the periods of the separate studies; no appreciable
secular trends were apparent within each individual study. Both
Indian and UK populations studied were urban, though both the
Indian study (a birth cohort based on a hospital providing
maternity care for the neighbouring population) and the UK study
(a survey based on primary schools) are likely to have
underrepresented children from extremely poor and extremely
affluent families. Had the comparison been based on Indian
children from semi-urban or rural settings, cardiometabolic
differences between UK and Indian populations could have been
even larger [27]. The regions of origin of the UK Indians
(predominantly Gujarat and to a lesser extent Punjab, both in
North India) are different from those of the Mysore population
(based in the Karnataka region in Southern India). However,
patterns of mean BMI and proportions of overweight or obesity in
Indian adults in Karnataka are similar to those in Gujarat and
those in India as a whole, though lower than those in Punjab [28];
rates of cardiovascular disease among Indian adults are similar in
Karnataka and Gujarat regions but lower than those in Punjab
[27]. However, the high levels of obesity and cardiovascular
disease currently observed in Punjab are likely to have developed
after the migration of families whose children participated in
CHASE. Moreover, restriction of analyses in CHASE children to
those specifically of Gujarat origin did not materially affect the
findings of UK Indian-Indian comparisons.
The cardiometabolic risk comparisons between UK Indians and
Mysore Indians complement those based on UK Indian-white
European comparisons alone [1,11–13]. If the markedly higher
total (and LDL) cholesterol, blood pressure and adiposity levels in
UK Indian children compared with Indians were to be maintained
into adult life, these could account for approximately 22%, 44%
and 29% higher CHD risks respectively at 40–49 years (potentially
2–3 fold combined) [29–31]. The higher BMI in UK Indians, if
maintained into adulthood, could also account for a T2D risk
approximately 60% higher than in Indians [30]. However, this
could be an underestimate both because adiposity from childhood
is likely to have a greater impact on T2D risk [32] and because the
BMI difference between UK and Mysore Indians is likely to have
underestimated the true difference in body fat (Figure 1).
Understanding the reasons for the population differences in
adiposity and cardiometabolic risk is potentially important for
prevention. Adiposity alone did not appear to explain the
population group differences in cardiometabolic risk; this is
consistent with the limited contribution of adiposity to differences
in insulin resistance and blood lipids between UK South Asians
and white Europeans in the main CHASE Study [12,33]. The
higher fat mass percentage at a given BMI observed among Indian
children both in the UK and in Mysore is consistent with earlier
observations in children [10] and adults [34] and with the concept
of the ‘thin-fat’ Indian child [35]. The finding emphasizes the
importance of using markers other than BMI for the assessment of
adiposity in South Asian children [10]. Diet and physical activity
are likely to play an important role in the population differences in
adiposity and cardiometabolic risk observed. It is likely that
differences in childhood diet (particularly higher intakes of calories
and saturated fat) contribute to the higher levels of adiposity and
circulating total, LDL and HDL-cholesterol and insulin levels in
UK Indians [33]. However, it was not possible to examine this
issue in detail in the present study because assessments of dietary
intake were collected using very different methods in the two
studies (24 hour recall in CHASE and food frequency question-
naire assessment in MPBCS). Low physical activity levels among
UK Indians are also likely to contribute to higher levels of
adiposity and insulin resistance [36]. Although we have shown in
an earlier report that UK South Asians, including Indians, have
lower objectively measured physical activity levels than UK white
Europeans, it was not possible to examine this issue in detail in the
present study because only 34% of the children in CHASE and
11% of children in MPBCS had objective physical activity
assessments using an Actigraph GT1M. Among the children
measured, mean levels of activity counts per minute (CPM) were
lowest among UK Indians (mean 433.6, 95% CI 413.2, 454.0),
intermediate among UK white Europeans (mean 492.5, 95% CI
483.3, 501.6) and highest among Mysore Indians (mean 515.8,
95% CI 476.5, 555.1). However, these differences, if representa-
tive of those in the populations studied, would not account for the
pattern of cardiometabolic risk levels observed (markedly lower in
Mysore Indians compared with both UK white Europeans and
UK Indians), nor for their size, when taking account of the
expected impact of these physical activity differences on
cardiometabolic risk in the CHASE Study population [37]. This
suggests that the contribution of physical activity to population
differences in cardiometabolic risk may well be small. The
contribution of other factors including socioeconomic status and
family size to the risk marker differences between Mysore and UK
Indians requires consideration, but is likely to be small. We have
reported elsewhere that there are no consistent associations
between socioeconomic status and cardiometabolic risk in UK
Indians [25]. Although higher socioeconomic status is associated
with higher levels of adiposity and insulin in Mysore Indians (data
not presented), the population-wide differences between Mysore
and UK Indians remain, even among participants with high
socioeconomic status. Family size (measured in CHASE but not in
MPBCS) is unrelated to cardiometabolic risk. Early life exposures,
particularly low birth weight, are associated with T2D and insulin
resistance [8,38]. However, mean birth weights were lowest in
Mysore Indian children [15], intermediate in UK Indians and
highest in UK white Europeans, both in CHASE (Nightingale
CM, unpublished data), suggesting that birth weight patterns alone
do not account for the higher cardiometabolic risk of UK Indian
children. Differences in family history of diabetes do not account
for the population differences observed, which remained un-
changed in a sensitivity analysis in which all children with parental
or grand parental history of diabetes were excluded from analysis.
The early emergence of these adverse cardiometabolic risk
profiles among UK Indian and white European children when
compared with Mysore Indian children emphasizes that efforts to
control chronic disease in the UK, especially in Indian diaspora
populations need to take a life course approach, including children
as well as adults. On this basis, population-wide improvements in
diet (particularly to reduce total energy, saturated fat and salt
intakes) and increases in physical activity levels are likely to be
particularly important priorities in preventing the emergence of
cardiometabolic risk in the next generation.
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